Literature DB >> 18519663

The roles of human sucrose nonfermenting protein 2 homologue in the tumor-promoting functions of Rsf-1.

Jim Jinn-Chyuan Sheu1, Jung Hye Choi, Isil Yildiz, Fuu-Jen Tsai, Yosef Shaul, Tian-Li Wang, Ie-Ming Shih.   

Abstract

Rsf-1 interacts with human sucrose nonfermenting protein 2 homologue (hSNF2H) to form a chromatin remodeling complex that participates in several biological processes. We have previously shown that Rsf-1 gene amplification was associated with the most aggressive type of ovarian cancer and cancer cells with Rsf-1 overexpression depended on Rsf-1 to survive. In this report, we determine if formation of the Rsf-1/hSNF2H complex could be one of the mechanisms contributing to tumor cell survival and growth in ovarian carcinomas. Based on immunohistochemistry, we found that Rsf-1 and hSNF2H were co-upregulated in ovarian cancer tissues. Ectopic expression of Rsf-1 in SKOV3 ovarian cancer cells with undetectable endogenous Rsf-1 expression enhanced hSNF2H protein levels and promoted SKOV3 tumor growth in a mouse xenograft model. Our studies also indicated that induction of Rsf-1 expression affected the molecular partnership of hSNF2H and translocated hSNF2H into nuclei where it colocalized with Rsf-1. Furthermore, analysis of Rsf-1 deletion mutants showed that the Rsf-D4 fragment contained the hSNF2H binding site based on coimmunoprecipitation and in vitro competition assays. As compared with other truncated mutants, expression of Rsf-D4 resulted in remarkable growth inhibition in ovarian cancer cells with Rsf-1 gene amplification and overexpression, but not in those without detectable Rsf-1 expression. The above findings suggest that interaction between Rsf-1 and hSNF2H may define a survival signal in those tumors overexpressing Rsf-1.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18519663      PMCID: PMC2628471          DOI: 10.1158/0008-5472.CAN-07-3240

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  32 in total

1.  A family of chromatin remodeling factors related to Williams syndrome transcription factor.

Authors:  D A Bochar; J Savard; W Wang; D W Lafleur; P Moore; J Côté; R Shiekhattar
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

Review 2.  ATP-dependent chromatin-remodeling complexes.

Authors:  M Vignali; A H Hassan; K E Neely; J L Workman
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

3.  Large-scale serial analysis of gene expression reveals genes differentially expressed in ovarian cancer.

Authors:  C D Hough; C A Sherman-Baust; E S Pizer; F J Montz; D D Im; N B Rosenshein; K R Cho; G J Riggins; P J Morin
Journal:  Cancer Res       Date:  2000-11-15       Impact factor: 12.701

4.  Expression of Rsf-1, a chromatin-remodeling gene, in ovarian and breast carcinoma.

Authors:  Tsui-Lien Mao; Chih-Yi Hsu; May J Yen; Blake Gilks; Jim Jinn-Chyuan Sheu; Edward Gabrielson; Russell Vang; Leslie Cope; Robert J Kurman; Tian-Li Wang; Ie-Ming Shih
Journal:  Hum Pathol       Date:  2006-07-07       Impact factor: 3.466

5.  Disruption of Ini1 leads to peri-implantation lethality and tumorigenesis in mice.

Authors:  C J Guidi; A T Sands; B P Zambrowicz; T K Turner; D A Demers; W Webster; T W Smith; A N Imbalzano; S N Jones
Journal:  Mol Cell Biol       Date:  2001-05       Impact factor: 4.272

6.  The murine SNF5/INI1 chromatin remodeling factor is essential for embryonic development and tumor suppression.

Authors:  A Klochendler-Yeivin; L Fiette; J Barra; C Muchardt; C Babinet; M Yaniv
Journal:  EMBO Rep       Date:  2000-12       Impact factor: 8.807

7.  HuCHRAC, a human ISWI chromatin remodelling complex contains hACF1 and two novel histone-fold proteins.

Authors:  R A Poot; G Dellaire; B B Hülsmann; M A Grimaldi; D F Corona; P B Becker; W A Bickmore; P D Varga-Weisz
Journal:  EMBO J       Date:  2000-07-03       Impact factor: 11.598

8.  Amplicon profiles in ovarian serous carcinomas.

Authors:  Kentaro Nakayama; Naomi Nakayama; Natini Jinawath; Ritu Salani; Robert J Kurman; Ie-Ming Shih; Tian-Li Wang
Journal:  Int J Cancer       Date:  2007-06-15       Impact factor: 7.396

9.  BRG1, a component of the SWI-SNF complex, is mutated in multiple human tumor cell lines.

Authors:  A K Wong; F Shanahan; Y Chen; L Lian; P Ha; K Hendricks; S Ghaffari; D Iliev; B Penn; A M Woodland; R Smith; G Salada; A Carillo; K Laity; J Gupte; B Swedlund; S V Tavtigian; D H Teng; E Lees
Journal:  Cancer Res       Date:  2000-11-01       Impact factor: 12.701

10.  Expression of the chromatin remodeling factor Rsf-1 is upregulated in ovarian carcinoma effusions and predicts poor survival.

Authors:  Ben Davidson; Claes G Trope'; Tian-Li Wang; Ie-Ming Shih
Journal:  Gynecol Oncol       Date:  2006-07-17       Impact factor: 5.482

View more
  30 in total

1.  Rsf-1, a chromatin remodeling protein, induces DNA damage and promotes genomic instability.

Authors:  Jim Jinn-Chyuan Sheu; Bin Guan; Jung-Hye Choi; Athena Lin; Chia-Huei Lee; Yi-Ting Hsiao; Tian-Li Wang; Fuu-Jen Tsai; Ie-Ming Shih
Journal:  J Biol Chem       Date:  2010-10-05       Impact factor: 5.157

2.  Overexpression of a chromatin remodeling factor, RSF-1/HBXAP, correlates with aggressive oral squamous cell carcinoma.

Authors:  Fu-Min Fang; Chien-Feng Li; Hsuan-Ying Huang; Ming-Tsong Lai; Chih-Mei Chen; I-Wen Chiu; Tian-Li Wang; Fuu-Jen Tsai; Ie-Ming Shih; Jim Jinn-Chyuan Sheu
Journal:  Am J Pathol       Date:  2011-05       Impact factor: 4.307

3.  Prognostic value of rsf-1/hbxap in human solid tumors: a meta-analysis of cohort studies.

Authors:  Jiayuan Wu; Liren Hu; Fenping Wu; Taiping He
Journal:  Int J Clin Exp Med       Date:  2015-02-15

4.  RSF1 is a positive regulator of NF-κB-induced gene expression required for ovarian cancer chemoresistance.

Authors:  Yeong-In Yang; Ji-Hye Ahn; Kyung-Tae Lee; Ie-Ming Shih; Jung-Hye Choi
Journal:  Cancer Res       Date:  2014-02-24       Impact factor: 12.701

5.  High RSF-1 expression correlates with poor prognosis in patients with gastric adenocarcinoma.

Authors:  Ben-Shun Hu; Hai-Feng Yu; Gao Zhao; Tian-Zhou Zha
Journal:  Int J Clin Exp Pathol       Date:  2012-09-05

6.  Overexpression of Rsf-1 correlates with pathological type, p53 status and survival in primary breast cancer.

Authors:  Jie Ren; Qiu-Chen Chen; Feng Jin; Hui-Zhe Wu; Miao He; Lin Zhao; Zhao-Jin Yu; Wei-Fan Yao; Xiao-Yi Mi; En-Hua Wang; Min-Jie Wei
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

7.  Rsf-1 (HBXAP) expression is associated with advanced stage and lymph node metastasis in ovarian clear cell carcinoma.

Authors:  Daichi Maeda; Xu Chen; Bin Guan; Shunsuke Nakagawa; Tetsu Yano; Yuji Taketani; Masashi Fukayama; Tian-Li Wang; Ie-Ming Shih
Journal:  Int J Gynecol Pathol       Date:  2011-01       Impact factor: 2.762

8.  Rsf-1 overexpression in human prostate cancer, implication as a prognostic marker.

Authors:  Hui Li; Yi Zhang; Yue Zhang; Xue Bai; Yang Peng; Ping He
Journal:  Tumour Biol       Date:  2014-03-01

9.  Serous tubal intraepithelial carcinoma upregulates markers associated with high-grade serous carcinomas including Rsf-1 (HBXAP), cyclin E and fatty acid synthase.

Authors:  Ann Smith Sehdev; Robert J Kurman; Elisabetta Kuhn; Ie-Ming Shih
Journal:  Mod Pathol       Date:  2010-03-12       Impact factor: 7.842

10.  Rsf-1, a chromatin remodelling protein, interacts with cyclin E1 and promotes tumour development.

Authors:  Jim Jinn-Chyuan Sheu; Jung Hye Choi; Bin Guan; Fuu-Jen Tsai; Chun-Hung Hua; Ming-Tsung Lai; Tian-Li Wang; Ie-Ming Shih
Journal:  J Pathol       Date:  2013-02-04       Impact factor: 7.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.